Director & Chairman of the Scientific Advisory Committee (SAC)
Associate Professor Peter Mollee
MBBS(Hons), MMedSc, FRACP, FRCPA
Peter, a SAC representative since 2012, currently Chairs the Myeloma Disease Group Committee, and co-chairs the High Grade Lymphoma Group. Peter is a member of the ALLG’s Finance and Audit Committee. He was appointed as the Chairman of the SAC in November 2017.
Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia and chairs the Scientific Advisory Committee of the Australasian Leukaemia and Lymphoma Group (ALLG). Dr Mollee also chairs the Myeloma Subgroup Committee of the ALLG and co-chairs the High Grade Lymphoma Subgroup.
Dr Mollee obtained a Masters in Clinical Epidemiology with a specialisation in Research Protocol Design and has a particular interest in the plasma cell dyscrasias, particularly AL amyloidosis. He heads the Myeloma Service as well as the Princess Alexandra Hospital Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.